Report Scope:

This report represents a current and important business tool to evaluate technologies, trends, products and market participants in the outsourcing sector for drug and medical device development. The geographic scope of this study covers the U.S. and companies worldwide.

Report Includes:

  • 22 data tables and 25 additional tables
  • An overview of the global outsourcing market for drug and medical device development and discussion on their services and technologies
  • Analyses of global market trends, with data from 2018, 2019, estimates for 2020, and projections of compound annual growth rates (CAGRs) through 2025
  • Identification of key challenges and opportunities in the drug and medical device development market and coverage of products and services related to different sectors of the industry
  • Information on ISO, GLP, cGMP regulatory aspects in drug development and discussion on their importance related to certification of specific facilities
  • A look at the ongoing activities in drug and device development process, their budget, timeline, resources and processes
  • Insights into regulatory framework, investment analysis, growth indicators and key decision supporting factors and evaluation of current market size, market forecast, and market share analysis of the leading players of the industry
  • Comprehensive profiles of major players in the industry, including Sterling Medical Devices, Evotec SE, Ajinomoto Althea, Eurofins Scientific, Charles River Laboratories Inc. and DeviceLab